CCL5 Composition for Skeletal Stem Cell Recruitment in Bone Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack the ability to specifically recruit skeletal stem cells (SSCs) to a specific site for bone repair, as there is a lack of specific markers to distinguish SSCs at different locations and the cellular complexity of injury models generated through disruption of the bone compartment's physical barrier, making the direct effect of cytokines on endogenous SSCs during injury healing unclear.
Innovation Solution
A composition comprising CCL5 is administered to a specific site in need, such as a bone break, fracture, or osteoporosis, to recruit periosteal skeletal stem cells (P-SSCs) and induce bone healing, which can be delivered with a biocompatible gel or scaffold, and may include additional therapies like surgical repair or fixation devices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple cytokines and growth factors are used to enhance skeletal repair, then bone healing is promoted, but the direct effect on endogenous SSCs remains unclear due to cellular complexity and lack of specific markers
Solution Approach 1:
The patent uses specific SSC markers (Nestin, CD105, CD140a) as intermediaries to identify and track skeletal stem cells during fracture repair. This allows researchers to distinguish SSCs from other cell types in the complex injury environment, thereby clarifying the direct effects of cytokines like CCL5 on these specific cells while maintaining the overall complexity of the bone healing process
Solution Approach 2:
The patent changes the parameter of cell identification from general morphological characteristics to specific molecular markers (Nestin, CD105, CD140a expression patterns). This parameter change enables precise tracking of SSCs within the complex cellular environment of fracture sites, allowing clear observation of cytokine effects on these specific cells
2Productivity
If SSCs are recruited to specific sites for bone repair, then fracture healing is enhanced, but the ability to specifically recruit SSCs to a specific site is currently lacking
Solution Approach 1:
The patent employs CCL5 cytokine administration that creates a feedback mechanism: CCL5 binds to CCR5 receptors on SSCs, triggering chemotactic migration toward the fracture site. This feedback loop ensures SSCs are specifically recruited to where they are needed (fracture sites with CCL5 expression) rather than being distributed randomly, thereby enhancing repair efficiency with precise spatial targeting
Solution Approach 2:
The patent uses CCL5-CCR5 interaction as an intermediary mechanism to achieve specific SSC recruitment. The CCL5 cytokine acts as a chemical signal that mediates the attraction of SSCs expressing CCR5 receptors to the fracture site, providing the specificity that was previously lacking in bone repair approaches
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The administration of CCL5 effectively recruits P-SSCs to differentiate into osteoblasts, aiding in bone healing and reducing osteoclast migration, thereby enhancing bone repair and regeneration.
Implementation Method 1
The administration of CCL5 effectively recruits P-SSCs to differentiate into osteoblasts
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
Embodiments of the disclosure encompass methods and compositions for bone repair and bone injury healing. In some embodiments, the bone repair and bone injury healing utilizes the enhancement of migration of certain types of bone cells upon stimulation by a particular cytokine. In specific embodiments, migration of periosteal skeletal stem cells upon delivery of CCL5 and/or TNFα is enhanced and fosters bone repair and healing.